{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:03:11Z","timestamp":1790636591868,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012157","name":"Shanghai Key Discipline Construction Project","doi-asserted-by":"publisher","award":["2023ZDZK01"],"award-info":[{"award-number":["2023ZDZK01"]}],"id":[{"id":"10.13039\/501100012157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbrc.2026.153305","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:30:00Z","timestamp":1768548600000},"page":"153305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cyclin D1 and the resistance landscape of HIF2 inhibition in clear-cell renal cell carcinoma: Insights from a mini-review"],"prefix":"10.1016","volume":"801","author":[{"given":"Zhenbang","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10451","key":"10.1016\/j.bbrc.2026.153305_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","article-title":"Renal cell carcinoma","volume":"404","author":"Young","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbrc.2026.153305_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103287","article-title":"Comprehensive review of chromophobe renal cell carcinoma","volume":"160","author":"Garje","year":"2021","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153305_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eururo.2021.12.010","article-title":"Genomics of clear-cell renal cell carcinoma: a systematic review and meta-analysis","volume":"81","author":"Bui","year":"2022","journal-title":"Eur. Urol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153305_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41585-024-00876-w","article-title":"Von Hippel-Lindau protein signalling in clear cell renal cell carcinoma","volume":"21","author":"Liao","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153305_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41392-023-01362-2","article-title":"Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153305_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/15548627.2024.2421699","article-title":"Atractylenolide I inhibits angiogenesis and reverses sunitinib resistance in clear cell renal cell carcinoma through ATP6V0D2-mediated autophagic degradation of EPAS1\/HIF2\u03b1","volume":"21","author":"Li","year":"2025","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153305_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2015.08.007","article-title":"Hypoxia, hypoxia-inducible transcription factors, and renal cancer","volume":"69","author":"Sch\u00f6del","year":"2016","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153305_bib8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jmri.29588","article-title":"Clear Cell Renal Cell Carcinoma: characterizing the Phenotype of Von Hippel-Lindau Mutation Using MRI","volume":"61","author":"Bai","year":"2025","journal-title":"J. Magn. Reson. Imag. : JMRI"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153305_bib9","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.7150\/ijbs.73398","article-title":"A positive feedback loop between inactive VHL-triggered histone lactylation and PDGFR\u03b2 signaling drives clear cell renal cell carcinoma progression","volume":"18","author":"Yang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"22","key":"10.1016\/j.bbrc.2026.153305_bib10","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"7627","key":"10.1016\/j.bbrc.2026.153305_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153305_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJMoa2313906","article-title":"Belzutifan versus everolimus for advanced renal-cell carcinoma","volume":"391","author":"Choueiri","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153305_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/phar.70023","article-title":"Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma","volume":"45","author":"Chen","year":"2025","journal-title":"Pharmacotherapy"},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2026.153305_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17512433.2024.2436433","article-title":"Targeting HIF-2\u03b1: the role of belzutifan in clear cell renal carcinoma management","volume":"18","author":"Vald\u00e9s","year":"2025","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153305_bib15","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1158\/2159-8290.CD-24-1378","article-title":"Requirement for Cyclin D1 underlies cell-autonomous HIF2 dependence in kidney cancer","volume":"15","author":"Shirole","year":"2025","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153305_bib16","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2-VEGF axis in renal cell carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153305_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173934","article-title":"VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis","volume":"134","author":"Wolf","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153305_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164249","article-title":"HIF-2\u03b1 expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma","volume":"134","author":"Bacigalupa","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.153305_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1195500","article-title":"Metabolic reprogramming of clear cell renal cell carcinoma","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.153305_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.34133\/research.0322","article-title":"HIF2\u03b1 promotes cancer metastasis through TCF7L2-Dependent fatty acid synthesis in ccRCC","volume":"7","author":"Shi","year":"2024","journal-title":"Research"},{"issue":"16","key":"10.1016\/j.bbrc.2026.153305_bib21","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s40265-021-01606-x","article-title":"Belzutifan: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153305_bib22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41591-021-01324-7","article-title":"Inhibition of hypoxia-inducible factor-2\u03b1 in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis","volume":"27","author":"Choueiri","year":"2021","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153305_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11912-022-01354-5","article-title":"Belzutifan (MK-6482): biology and clinical development in solid tumors","volume":"25","author":"Choi","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbrc.2026.153305_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251317846","article-title":"Belzutifan for the treatment of renal cell carcinoma","volume":"17","author":"Wu","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"24","key":"10.1016\/j.bbrc.2026.153305_bib25","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1158\/1078-0432.CCR-22-0963","article-title":"HIF2 inactivation and tumor suppression with a tumor-directed RNA-Silencing drug in mice and humans","volume":"28","author":"Ma","year":"2022","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153305_bib26","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","article-title":"Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment","volume":"162","author":"Garcia Garcia","year":"2022","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153305_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1042\/EBC20220016","article-title":"WNT signaling and cancer stemness","volume":"66","author":"Katoh","year":"2022","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bbrc.2026.153305_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.895729","article-title":"Prognostic and predictive value of CCND1\/Cyclin D1 amplification in breast cancer with a focus on postmenopausal patients: a systematic review and meta-analysis","volume":"13","author":"Jeffreys","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153305_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/annonc\/mdu449","article-title":"A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage","volume":"26","author":"Findlay","year":"2015","journal-title":"Ann. Oncol. : official journal of the European Society for Medical Oncology"},{"issue":"19","key":"10.1016\/j.bbrc.2026.153305_bib30","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1200\/JCO.2013.49.1316","article-title":"Primary CNS CCND1\/MYC-Positive double-hit B-Cell lymphoma: a case report and review of the literature","volume":"33","author":"Sakurai","year":"2015","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153305_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-019-1097-0","article-title":"HER2 regulates HIF-2\u03b1 and drives an increased hypoxic response in breast cancer","volume":"21","author":"Jarman","year":"2019","journal-title":"Breast Cancer Res."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153305_bib32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1200\/JCO.2017.77.5254","article-title":"HIF2 inhibitor joins the kidney cancer armamentarium","volume":"36","author":"Kaelin","year":"2018","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153305_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/endrev\/bnac025","article-title":"Hypoxia-inducible factor 2 alpha (HIF2\u03b1) inhibitors: targeting genetically driven tumor hypoxia","volume":"44","author":"Toledo","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2026.153305_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.semcancer.2023.09.002","article-title":"Targeting intratumoral hypoxia to enhance anti-tumor immunity","volume":"96","author":"Semenza","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153305_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1566524018666181109121849","article-title":"Role of HIF-1 in cancer progression: novel insights. A review","volume":"18","author":"Pezzuto","year":"2018","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153305_bib36","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le Floc'h","year":"2020","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153305_bib37","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1021\/acs.molpharmaceut.4c00104","article-title":"A CAIX dual-targeting small-molecule probe for noninvasive imaging of ccRCC","volume":"21","author":"He","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2026.153305_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2023.103604","article-title":"NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation","volume":"133","author":"Zhang","year":"2024","journal-title":"DNA Repair"},{"issue":"9","key":"10.1016\/j.bbrc.2026.153305_bib39","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1002\/cam4.2313","article-title":"Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2026.153305_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144994","article-title":"MicroRNAs as regulators of VEGFA and NFE2L2 in cancer","volume":"759","author":"Cuzziol","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2026.153305_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.110","article-title":"ADAMTS8 inhibited lung cancer progression through suppressing VEGFA","volume":"598","author":"Zhang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.bbrc.2026.153305_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-\u03baB activation: a review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153305_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","article-title":"Overexpressed cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors","volume":"66","author":"Cai","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153305_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1389557520999201124212347","article-title":"Dual modulators of p53 and cyclin D in ER alpha signaling by albumin nanovectors bearing zinc chaperones for ER-positive breast cancer therapy","volume":"21","author":"P","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153305_bib45","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1111\/jcmm.13588","article-title":"MICAL1 facilitates breast cancer cell proliferation via ROS-Sensitive ERK\/Cyclin D pathway","volume":"22","author":"Deng","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"17","key":"10.1016\/j.bbrc.2026.153305_bib46","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2174\/0118715206377378250414052656","article-title":"Identification of flavonoid-based hypoxia-inducible Factor-2 alpha inhibitors for the treatment of breast Cancer- in silico and in vitro evidence","volume":"25","author":"Shahinaz","year":"2025","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153305_bib47","doi-asserted-by":"crossref","DOI":"10.1124\/molpharm.122.000525","article-title":"Structural basis for the allosteric inhibition of hypoxia-inducible factor (HIF)-2 by belzutifan","volume":"102","author":"Ren","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153305_bib48","article-title":"The clinical role of hypoxia inducible factor (HIF) inhibition in renal cancer: a focus on Belzutifan","author":"Arduini","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153305_bib49","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1038\/s41598-018-21073-x","article-title":"Hypoxia induces pulmonary fibroblast proliferation through NFAT signaling","volume":"8","author":"Senavirathna","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153305_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ng.2204","article-title":"Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression","volume":"44","author":"Sch\u00f6del","year":"2012","journal-title":"Nat. Genet."},{"issue":"22","key":"10.1016\/j.bbrc.2026.153305_bib51","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1158\/0008-5472.CAN-20-1232","article-title":"Hypoxia alters the response to Anti-EGFR therapy by regulating EGFR expression and downstream signaling in a DNA methylation-specific and HIF-dependent manner","volume":"80","author":"Mamo","year":"2020","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153305_bib52","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202401056","article-title":"PC4: a new regulator of cyclin D1 transcript levels","volume":"223","author":"Fassl","year":"2024","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153305_bib53","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1172\/JCI96520","article-title":"Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms","volume":"128","author":"Albero","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153305_bib54","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J. Mol. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:57:18Z","timestamp":1769795838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":54,"alternative-id":["S0006291X26000690"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153305","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclin D1 and the resistance landscape of HIF2 inhibition in clear-cell renal cell carcinoma: Insights from a mini-review","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153305"}}